Apis Capital Advisors LLC Sells 174,000 Shares of Celcuity, Inc. $CELC

Apis Capital Advisors LLC decreased its position in shares of Celcuity, Inc. (NASDAQ:CELC) by 22.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 602,000 shares of the company’s stock after selling 174,000 shares during the period. Celcuity makes up about 10.5% of Apis Capital Advisors LLC’s portfolio, making the stock its biggest holding. Apis Capital Advisors LLC’s holdings in Celcuity were worth $60,043,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in CELC. Avoro Capital Advisors LLC acquired a new stake in shares of Celcuity during the 4th quarter worth approximately $310,302,000. NEA Management Company LLC boosted its position in shares of Celcuity by 64.9% during the 4th quarter. NEA Management Company LLC now owns 3,535,561 shares of the company’s stock worth $352,637,000 after acquiring an additional 1,391,300 shares in the last quarter. State Street Corp boosted its position in shares of Celcuity by 126.6% during the 4th quarter. State Street Corp now owns 1,637,687 shares of the company’s stock worth $163,343,000 after acquiring an additional 914,887 shares in the last quarter. UBS Group AG boosted its position in shares of Celcuity by 910.1% during the 3rd quarter. UBS Group AG now owns 854,483 shares of the company’s stock worth $42,211,000 after acquiring an additional 769,891 shares in the last quarter. Finally, Deerfield Management Company L.P. acquired a new stake in shares of Celcuity during the 3rd quarter worth approximately $36,236,000. Institutional investors and hedge funds own 63.33% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CELC. Guggenheim reiterated a “buy” rating on shares of Celcuity in a research report on Wednesday, June 3rd. Craig Hallum reduced their price target on shares of Celcuity from $189.00 to $171.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Citizens Jmp increased their price target on shares of Celcuity from $150.00 to $160.00 and gave the stock a “market outperform” rating in a research report on Monday, May 4th. Citigroup restated a “market outperform” rating on shares of Celcuity in a research report on Thursday, May 28th. Finally, HC Wainwright cut their target price on shares of Celcuity from $185.00 to $145.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Eleven investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $152.09.

Insider Buying and Selling at Celcuity

In other news, Director Richard E. Buller sold 9,000 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the completion of the transaction, the director owned 6,760 shares of the company’s stock, valued at approximately $949,509.60. This trade represents a 57.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director David Dalvey sold 25,000 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $140.68, for a total transaction of $3,517,000.00. Following the transaction, the director directly owned 65,000 shares of the company’s stock, valued at $9,144,200. The trade was a 27.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,000 shares of company stock valued at $5,111,950 in the last ninety days. Insiders own 13.33% of the company’s stock.

Celcuity Price Performance

CELC stock opened at $88.05 on Thursday. The company has a fifty day moving average price of $118.29 and a 200-day moving average price of $111.04. The company has a market capitalization of $4.29 billion, a P/E ratio of -22.58 and a beta of 0.10. Celcuity, Inc. has a 52-week low of $11.27 and a 52-week high of $151.02. The company has a debt-to-equity ratio of 6.04, a quick ratio of 12.31 and a current ratio of 12.31.

Celcuity (NASDAQ:CELC) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.97) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.07) by $0.10. As a group, equities analysts expect that Celcuity, Inc. will post -3.69 EPS for the current year.

Celcuity Company Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.